comparemela.com

Latest Breaking News On - Prnewswire bloomios inc - Page 1 : comparemela.com

Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2 75 Million

Annualized Run Rate Hits $11.0 Million vs. $6.1 million in 2022, Driven by Increased Order Flow and Production Capacity Q2 2023 Outlook of Revenues to Exceed $3 million, up more than 137% SANTA. | June 1, 2023

United statesDaytona beachMichael hillTim randallJoe reidSanta barbaraDoug rohrerCompany contactSecurities exchangeExchange commissionConvertibles related partyPrnewswire bloomios incBloomios incAnnualized run rate hitsIncreased order flowBloomios private label

Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2 75 Million

/PRNewswire/ Bloomios, Inc. (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and.

United statesDaytona beachSanta barbaraDoug rohrerMichael hillTim randallJoe reidConvertibles related partyBloomios incPrnewswire bloomios incSecurities exchangeCompany contactExchange commissionAnnualized run rate hitsIncreased order flowBloomios private label

Bloomios Completes $23 5 Million Acquisition of Leading Gummy Manufacturer

Transaction Expected to Double Production Capacity and Supports Entry of Direct-to-Consumer MarketSANTA BARBARA, Calif., Oct. 27, 2022 /PRNewswire.

United statesDaytona beachDoug rohrerTim randallMichael hillSanta barbaraBarrett evansPrnewswire bloomios incExchange commissionCompany formBloomios incCompany contactTransaction expectedDouble production capacitySupports entrySeriesd convertible preferred stock

Bloomios Completes $23 5 Million Acquisition of Leading Gummy Manufacturer

/PRNewswire/ Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived.

United statesDaytona beachDoug rohrerTim randallMichael hillSanta barbaraBarrett evansPrnewswire bloomios incExchange commissionCompany formBloomios incCompany contactTransaction expectedDouble production capacitySupports entrySeriesd convertible preferred stock

Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion s Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients

/PRNewswire/ Bloomios, Inc. (OTCQB: BLMS), a leading hemp and nutraceutical manufacturer specializing in full service product development, R&D and.

United statesDaytona beachMichael hillTim randallSanta barbaraJustin lumleyPrnewswire bloomios incNational institute on drug abuseBloomios incDrug administration disclosureSoutheast asiaDrug abuseBloomios privatePrivate securities litigation reform actDrug administrationRelations contact

vimarsana © 2020. All Rights Reserved.